Skip to content

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06281080
Enrollment
10
Registered
2024-02-28
Start date
2024-11-20
Completion date
2026-03-31
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Brief summary

This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system.

Interventions

PROCEDUREEn-Bloc Resection of Bladder Tumours

Patients underwent En-Bloc Resection of Bladder Tumours using Agilis Robotic System.

Sponsors

Agilis Robotics Limited
CollaboratorUNKNOWN
Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Age between 18 and 75 years 2. Body mass index \<35 kg/m2 3. Bladder tumour located \<3 cm in size; clinically non-muscle invasive bladder tumour 4. Clinically indicated for en-bloc resection. 5. Willingness to participate as demonstrated by giving informed consent

Exclusion criteria

1. Presence of endoscopic or imaging signs of detrusor muscle invasion 2. Contraindication to general anaesthesia / spinal anaesthesia 3. ASA \> 2 patients 4. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention 5. Untreated active infection 6. Un-corrected coagulopathy 7. Presence of another malignancy or distant metastasis 8. Emergency surgery 9. Vulnerable population (e.g. mentally disabled, pregnant)

Design outcomes

Primary

MeasureTime frameDescription
Successful en-bloc tumour resection by the robotic systemDuring the operationThe number of cases completed the intervention by robotic system

Secondary

MeasureTime frameDescription
Total procedure timeDuring operationTime from insertion of the robotic system into urethra until removal of the specimen from the body
Surgeon Console timeDuring operationFrom the time start of any procedure to completion of urethral catheter insertion
Presence of detrusor muscle in specimenDuring operationPresence of detrusor muscle in specimen
Resection MarginDuring operationNumber of subject with Negative resection margin
Dissection time and speedDuring operationTime required for submucosal dissection from the first cut
Post-operative complicationsWithin 90 days after the study interventionComplication is defined according to the Clavien-Dindo Classification
Need of bladder irrigationWithin 30 days after the study intervention.Number of subject
Residual tumour or upstaging of tumour after second look TURBTWithin 30 days after the study intervention.Number of subject
Intra-operative bladder perforation eventDuring operationNumber of subject

Countries

Hong Kong

Contacts

Primary ContactChi Fai NG, MD
ngcf@surgery.cuhk.edu.hk35052625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026